You don't need to be signed in to read BMJ Blogs, but you can register here to receive updates about other BMJ products and services via our site.

Cardiac arrest

Amiodarone and lidocaine in refractory cardiac arrest

18 Apr, 17 | by flee

Out of hospital cardiac arrest with shock-refractory ventricular tachycardia (VT) or fibrillation (VF) carries a severe prognosis.  Despite their frequent use and guideline inclusion in this scenario, evidence that amiodarone or lidocaine improve survival is lacking. In this large multicenter randomized controlled double-blind trial, 3026 adult patients with spontaneously occurring out-of-hospital cardiac arrest and shock-refractory VT or VF were randomized by paramedics to treatment with amiodarone (974), lidocaine (993) or saline placebo (1059), along with standard care.  After presentation to the hospital, patients received open-label drugs, emergent angiography, and cooling as clinically indicated.  The primary outcome was survival to discharge with secondary outcomes including neurological and functional status in survivors.  Mean time to paramedic arrival and study drug administration were 8 and 19 minutes respectively.  There was no significant survival difference between the three groups (24.4%, 23.7%, and 21.0% respectively), nor differences in important neurologic outcomes. Treatment with amiodarone did result in shorter CPR times and fewer shocks but also had a higher rate of subsequent cardiac pacing.  In the sub-group of patients with a witnessed arrest, both amiodarone and lidocaine significantly improved survival (27.7% vs. 27.8% vs. 22.7%) and this effect was even more apparent when the arrest was witnessed by the paramedic crew (absolute risk reduction of 21.9%), though the trial was not sufficiently powered for these secondary analyses.

more…

Latest from Heart

Latest from Heart

Cardiology Masterclasses

Cardiology Masterclasses